Item 4. Controls and Procedures
Item 4. Controls and Procedures
Disclosure Controls and Procedures
Disclosure controls
are procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed
under the Exchange Act, such as this Form 10-Q, is recorded, processed, summarized and reported within the time periods specified
in the SEC’s rules and forms. Disclosure controls are also designed with the objective of ensuring that such information
is accumulated and communicated to our management, including the Principal Executive Officer and Principal Financial Officer, as
appropriate, to allow timely decisions regarding required disclosure. Internal controls are procedures which are designed with
the objective of providing reasonable assurance that (1) our transactions are properly authorized, recorded and reported; and (2)
our assets are safeguarded against unauthorized or improper use, to permit the preparation of our condensed consolidated financial
statements in conformity with GAAP.
In connection with
our annual report on Form 10-K for the year ended December 31, 2019, we reported a material weakness in our internal controls over
financial reporting resulting from the determination following initial audit procedures that the documentation underlying the preparation
of forward projections, which included copies of customer contracts underlying the basis of projecting revenues and support for
the projected cost structures associated with determining the fair value of the Sysorex note as of December 31, 2019, was not supportable
thereby requiring material adjustments to be made to the carrying value of the note as determined by management as of December
31, 2019. To address the material weakness, we have enhanced our internal technical accounting capabilities by engaging and using
third-party advisors to assist in areas requiring specialized technical accounting expertise, including with respect to designing
the procedures and processes associated with assessing the fair value of our equity and debt instruments. We have tested these
measures and believe these measures have enabled us to remediate the underlying control deficiency that gave rise to the previously
disclosed material weakness.
50
As a result, and in
connection with the preparation of this Form 10-Q, management, with the participation of our Principal Executive Officer and Principal
Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined
in Exchange Act Rule 13a-15(e) and 15d-15(e)). Based upon that evaluation, our Principal Executive Officer and Principal Financial
Officer concluded that, as of the end of the period covered by this Form 10-Q, our disclosure controls and procedures were effective.
Changes in Internal Controls
Remediation Measures
With the exception
of the remediation efforts described above there have been no changes in our internal control over financial reporting identified
in connection with the evaluation required by paragraph (d) of Rule 13a-15 or 15d-15 under the Exchange Act that occurred during
the quarter ended June 30, 2020 that has materially affected, or is reasonably likely to materially affect, our internal control
over financial reporting. The Company’s management determined that there were no material changes needed to internal controls as
a result of the COVID-19 pandemic.
Limitations of the Effectiveness of Control
A control system, no
matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control
system are met. Because of the inherent limitations of any control system, no evaluation of controls can provide absolute assurance
that all control issues, if any, within a company have been detected.
51
PART II—OTHER INFORMATION
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.